Brokerages expect Endava PLC – (NYSE:DAVA) to announce $105.60 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Endava’s earnings, with estimates ranging from $105.44 million to $105.67 million. Endava posted sales of $98.49 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 7.2%. The company is expected to issue its next earnings report on Wednesday, September 23rd.
On average, analysts expect that Endava will report full-year sales of $407.98 million for the current fiscal year, with estimates ranging from $346.99 million to $423.46 million. For the next fiscal year, analysts expect that the company will report sales of $474.19 million, with estimates ranging from $414.83 million to $491.36 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that follow Endava.
Several research firms have commented on DAVA. Citigroup upped their price target on shares of Endava from $49.00 to $57.00 and gave the company a “neutral” rating in a report on Friday, July 17th. Needham & Company LLC upped their price target on shares of Endava from $40.00 to $58.00 and gave the company a “buy” rating in a report on Thursday, May 21st. Morgan Stanley initiated coverage on shares of Endava in a report on Monday, June 15th. They issued an “equal weight” rating and a $54.00 price target on the stock. William Blair reissued an “outperform” rating on shares of Endava in a research note on Monday, August 17th. Finally, Wedbush initiated coverage on shares of Endava in a research note on Tuesday, May 26th. They set an “outperform” rating and a $60.00 target price on the stock. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $53.63.
NYSE:DAVA traded down $1.02 during mid-day trading on Monday, hitting $51.86. The company’s stock had a trading volume of 264,800 shares, compared to its average volume of 148,880. Endava has a 1 year low of $27.21 and a 1 year high of $56.76. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.09 and a quick ratio of 2.08. The stock has a market cap of $2.75 billion, a price-to-earnings ratio of 99.73, a PEG ratio of 3.03 and a beta of 1.16. The business’s fifty day moving average is $53.52 and its two-hundred day moving average is $47.22.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Captrust Financial Advisors acquired a new position in shares of Endava during the 2nd quarter worth about $34,000. Royal Bank of Canada acquired a new position in shares of Endava during the 1st quarter worth about $28,000. US Bancorp DE acquired a new stake in Endava in the 1st quarter valued at about $33,000. Bank of America Corp DE raised its holdings in Endava by 294.3% in the 4th quarter. Bank of America Corp DE now owns 1,325 shares of the company’s stock valued at $62,000 after acquiring an additional 989 shares during the last quarter. Finally, Tower Research Capital LLC TRC acquired a new stake in Endava in the 1st quarter valued at about $62,000. Hedge funds and other institutional investors own 36.87% of the company’s stock.
Endava plc provides technology services for clients in the consumer products, healthcare, logistics, and retail verticals in Europe, Latin America, and the United States. It offers strategy, creative and user experience, insights through data, mobile and Internet of Things, architecture, smart automation, software engineering, test automation and engineering, continuous delivery, cloud, applications management, and smart desk services across the digital evolution, agile transformation, and automation solution areas.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.